References:
1. Reindollar RH, Novak M, Tho SPT, McDonough PG. Adult-onset amenorrhea: A study of 262 patients. American Journal of Obstetrics and Gynecology. 1986 Sep;155(3):531–41.
2. Current evaluation of amenorrhea. Fertility and Sterility. 2006 Nov;86(5):S148–55.
3. Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage-results from a UK-population-based case-control study. BJOG: An International Journal of Obstetrics & Gynaecology. John Wiley & Sons, Ltd; 2007 Feb;114(2):170–86.
4. Han Z, Mulla S, Beyene J, Liao G, McDonald SD. Maternal underweight and the risk of preterm birth and low birth weight: a systematic review and meta-analyses. International Journal of Epidemiology. 2010 Nov 20;40(1):65–101.
5. Taskin O, Gokdeniz R, Muderrisoglu H, Korkmaz M, Uryan, I, Atmaca R et al. The effects of hormone replacement therapy on echocardiographic basic cardiac functions in postmenopausal women. Human Reproduction. 1998 Sep 1;13(9): 2399-2401.
6. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994 Apr 1;89(4):1501–10.
7. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N. Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice. J Clin Invest. American Society for Clinical Investigation; 2001 Feb 1;107(3):333–40.
8. Perkins R, Hall J, Martin K. Aetiology, previous menstrual function and patterns of neuro-endocrine disturbance as prognostic indicators in hypothalamic amenorrhoea. Human Reproduction. 2001;16(10): 2198-2205.
9. Gordon C, Ackerman K, Berga S, Kaplan J, Mastorakos G, Misra M.Murad, et al. Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2017;102(5):1413-1439.
10. Dumitrescu R, Mehedintu C, Briceag I, Purcarea VL, Hudita D. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms. Journal of Medicine and Life. Carol Davila - University Press; 2015 Apr;8(2):142–5.
11. Sum M, Warren MP. Hypothalamic amenorrhea in young women with underlying polycystic ovary syndrome. Fertility and Sterility. Elsevier; 2009 Dec 1;92(6):2106–8.
12. Robin G, Gallo C, Catteau-Jonard S, Lefebvre-Maunoury C Pigny P, Duhamel A et al. Polycystic Ovary-Like Abnormalities (PCO-L) in Women with Functional Hypothalamic Amenorrhea. The Journal of Clinical Endocrinology & Metabolism. 2012;97(11): 4236-4243.
13. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2013 Dec;98(12):4565–92.
14. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 2004;81(1):19-25.
15. Office IL. International standard classification of occupations: ISCO-88. 1990. [Internet]. Available from: https://www.ilo.org/wcmsp5/groups/public/---dgreports/---dcomm/---publ/documents/publication/wcms_172572.pdf
16. Aubuchon M, Liu Y, Petroski GF, Thomas TR, Polotsky AJ. The impact of supervised weight loss and intentional weight regain on sex hormone binding globulin and testosterone in premenopausal women. Systems Biology in Reproductive Medicine. Taylor & Francis; 2016 May 18;62(4):283–9.
17. Bradbury R, Lee P, Smith H. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2017;57(5): 552-557.
18. Stepto N, Cassar S, Joham A, Hutchison S, Harrison C, Goldstein R, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Human Reproduction. 2013;28(3): 777-784.
19. McEwen BS. Allostasis and Allostatic Load: Implications for Neuropsychopharmacology. Neuropsychopharmacol. Nature Publishing Group; 2000 Feb 1;22(2):108–24.
20. Wilmore JH, Brown CH, Davis JA. Body physique and composition of the female distance runner. Annals of the New York Academy of Sciences. John Wiley & Sons, Ltd; 1977 Oct 1;301(1):764–76.
21. Loucks AB. Low Energy Availability in the Marathon and Other Endurance Sports. Sports Med. Springer International Publishing; 2007 Apr 1;37(4):348–52.
22. Bachmann GA, Kemmann E. Prevalence of oligomenorrhea and amenorrhea in a college population. American Journal of Obstetrics and Gynecology. Mosby; 1982 Sep;144(1):98–102.
23. Andrico S, Gambera A, Specchia C, Pellegrini C, Falsetti L, Sartori E. Leptin in functional hypothalamic amenorrhoea. Human Reproduction. 2002;17(8):2043-2048.
24. Andrisani A, Sabbadin C, Minardi S, Favaro A, Donà G, Bordin L, et al. Persistent amenorrhea and decreased DHEAS to cortisol ratio after recovery from anorexia nervosa. Gynecological Endocrinology. 4 ed. Taylor & Francis; 2016 Dec 2;33(4):311–4.
25. Biller BM, Coughlin JF, Saxe V, Schoenfeld D, Spratt DI, Klibanski A. Osteopenia in women with hypothalamic amenorrhea: a prospective study. Obstet Gynecol. 1991 Dec;78(6):996-1001.
26. Pollock N, Grogan C, Perry M, Pedlar C, Cooke K, Morrissey D, et al. Bone-mineral density and other features of the female athlete triad in elite endurance runners: a longitudinal and cross-sectional observational study. Int J Sport Nutr Exerc Metab. Human Kinetics, Inc; 2010 Oct;20(5):418–26.
27. Warren MP, Voussoughian F, Geer EB, Hyle EP, Adberg CL, Ramos RH. Functional hypothalamic amenorrhea: hypoleptinemia and disordered eating. The Journal of Clinical Endocrinology & Metabolism. 1999 Mar;84(3):873–7.
28. Colombo O, Pinelli G, Comelli M, Marchetti P, Sieri S, Brighenti F, et al. Dietary intakes in infertile women a pilot study. Nutr J. BioMed Central; 2009 Nov 10;8(1):53–9.
29. Rodino IS, Byrne SM, Sanders KA. Eating disorders in the context of preconception care: fertility specialists’ knowledge, attitudes, and clinical practices. Fertility and Sterility. 2017 Feb;107(2):494–501.
30. Stewart DE, Raskin J, Garfinkel PE, MacDonald OL, Robinson GE. Anorexia nervosa, bulimia, and pregnancy. American Journal of Obstetrics and Gynecology. 1987 Nov;157(5):1194–8.
31. Freizinger M, Franko DL, Dacey M, Okun B, Domar AD. The prevalence of eating disorders in infertile women. Fertility and Sterility. 2010 Jan;93(1):72–8.
32. Wang JG, Lobo RA. The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism. 2008 Apr;93(4):1394–7.
33. Gordon CM. Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med. 2010 Jul 22;363(4):365–71.
34. Berga SL, Mortola JF, Girton L, Suh B, Laughlin G, Pham P, et al. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. The Journal of Clinical Endocrinology & Metabolism. 1989 Feb;68(2):301–8.
35. Laughlin GA, Dominguez CE, Yen SS. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. The Journal of Clinical Endocrinology & Metabolism. 1998 Jan;83(1):25–32.
36. Dickey RP, Holtkamp DE. Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update. 1996 Nov;2(6):483–506.
37. Messinis IE. Ovulation induction: a mini review. Hum Reprod. 2005 Oct;20(10):2688–97.
38. Smith V, Osianlis T, Vollenhoven B. Prevention of Ovarian Hyperstimulation Syndrome: A Review. Obstet Gynecol Int. Hindawi; 2015;2015(2):514159–10.
Table 1. Comparing clinical and biochemical features of women with FHA versus PCOS . Abbreviations: LH, luteinising hormone; FSH, follicle-stimulating hormone; TSH, thyroid-stimulating hormone; T4, thyroxine. * denotes where differences between FHA and PCOS groups were statistically significant at p < 0.05.